We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

KA Kineta Inc

-0.18 (-4.14%)
After Hours
Last Updated: 15:00:42
Delayed by 15 minutes


Draw Mode:

Volume 8,957
Bid Price 3.81
Ask Price 4.44
News -
Day High 4.5001


52 Week Range


Day Low 4.17
Share Name Share Symbol Market Stock Type
Kineta Inc KA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.18 -4.14% 4.17 15:00:42
Open Price Low Price High Price Close Price Previous Close
4.26 4.17 4.5001 4.17 4.35
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
159 8,957 US$ 4.41 US$ 39,500 - 1.7799 - 9.00
Last Trade Type Quantity Price Currency
15:00:00 124 US$ 4.39 USD

Kineta Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
19.64M 10.39M - 1.95M -63.41M -6.10 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Kineta News

Date Time Source News Article
11/30/202316:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/13/202316:28Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]
11/06/202307:30Edgar (US Regulatory)Form 8-K - Current report
11/03/202315:25Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of..
11/03/202315:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/03/202315:02Edgar (US Regulatory)Form 8-K - Current report
11/03/202315:01Edgar (US Regulatory)Form 8-K - Current report
10/20/202312:04Edgar (US Regulatory)Form D - Notice of Exempt Offering of Securities
10/17/202307:32Edgar (US Regulatory)Form 8-K - Current report
10/12/202315:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
10/05/202315:05Edgar (US Regulatory)Form 8-K - Current report
10/05/202309:47Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No KA Message Board. Create One! See More Posts on KA Message Board See More Message Board Posts

Historical KA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.434.773.434.1517,7200.7421.57%
1 Month4.184.772.993.6714,462-0.01-0.24%
3 Months2.115.391.933.4130,9082.0697.63%
6 Months3.045.391.77992.9625,4261.1337.17%
1 Year8.889.001.77993.9627,694-4.71-53.04%
3 Years8.889.001.77993.9627,694-4.71-53.04%
5 Years8.889.001.77993.9627,694-4.71-53.04%

Kineta Description

Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's lead asset is KVA12.1, a VISTA blocking immunotherapy.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |